Skip to Content
Ophthalmic Eye Drops — ALPHRIN, DORTMOX & Advanced Molecules | Agaaz Ophthalmics
AGAAZ OPHTHALMICS
Eye DropsClinic + OT12+ Molecules

Eye DropsALPHRIN · DORTMOX · Advanced Molecules

A focused ophthalmic eye drops portfolio — two flagship products for clinic and perioperative use, plus advanced molecule manufacturing capabilities for qualified distribution partners.

2 Flagship
ALPHRIN + DORTMOX
10+ Molecules
Advanced Capabilities
6 Categories
Glaucoma to Dry Eye
ALPHRIN Brimonidine Eye Drops by Agaaz Ophthalmics
+ ALPHRIN Brimonidine
+ DORTMOX Moxifloxacin
FLAGSHIP PRODUCTS

Two drops, built for the workflow.

Premium-positioned eye drops designed to sit naturally beside the intraocular product range — clean labelling, consistent presentation, clinical clarity.

Pressure control
ALPHRIN
Brimonidine Ophthalmic Solution
A focused IOP-control drop positioned for glaucoma and ocular hypertension management workflows. Selective alpha‑2 adrenergic agonist — reduces aqueous production and increases uveoscleral outflow.
Category
Anti-Glaucoma
Molecule
Brimonidine
Use
IOP Management
Setting
Clinic Regimen
Topical antibiotic
DORTMOX
Moxifloxacin Ophthalmic Solution
A 4th-generation fluoroquinolone topical antibiotic positioned for bacterial conjunctivitis treatment and perioperative prophylaxis in cataract surgery. Broad-spectrum gram‑positive and gram‑negative coverage.
Category
Antibiotic
Molecule
Moxifloxacin
Use
Periop + Clinic
Spectrum
Gram +/−
THE DROP JOURNEY

From bottle to tissue.

Every drop follows the same path — precise dispensing, corneal contact, absorption, and therapeutic action.

CORNEA TEAR FILM IRIS ANTERIOR CHAMBER

Precision Delivery

Topical ophthalmic drops deliver active molecules through the cornea to the anterior segment — concentration, contact time, and formulation stability determine therapeutic efficacy.

01
Dispense
Precise drop forms at tip
02
Contact
Drop meets tear film
03
Absorb
Corneal penetration
04
Act
Therapeutic action begins
ADVANCED MANUFACTURING

Next-generation molecules.
Built to order.

Beyond ALPHRIN and DORTMOX, Agaaz has established manufacturing capabilities for a range of advanced ophthalmic molecules and fixed-dose combinations. These formulations are available to qualified distribution partners with committed volume plans — enabling access to new-generation eye care products through a single trusted manufacturing source.

✦ Available to select partners on volume commitment
💧
Cyclosporine Ophthalmic Solution
Dry Eye / Immunomodulator
💧
Sodium Hyaluronate Ophthalmic Solution
Dry Eye / Lubricant
🛡
Olopatadine Ophthalmic Solution
Anti-Allergy / Antihistamine
🛡
Bepotastine Besilate Ophthalmic Solution
Anti-Allergy / Antihistamine
🔬
Nepafenac Ophthalmic Suspension
Anti-Inflammatory / NSAID
Moxifloxacin + Ketorolac Ophthalmic Solution
Antibiotic + Anti-Inflammatory Combo
👁
Brimonidine + Timolol Ophthalmic Solution
Anti-Glaucoma / Fixed-Dose Combo
👁
Dorzolamide + Timolol Ophthalmic Solution
Anti-Glaucoma / Fixed-Dose Combo
👁
Travoprost Ophthalmic Solution
Anti-Glaucoma / Prostaglandin
👁
Travoprost + Timolol Ophthalmic Solution
Anti-Glaucoma / Fixed-Dose Combo
FREQUENTLY ASKED QUESTIONS

Common questions about
Agaaz eye drops.

For distributors, procurement teams, and clinic operators.

Agaaz manufactures ALPHRIN (Brimonidine) for glaucoma/IOP management and DORTMOX (Moxifloxacin) as a topical antibiotic. Additionally, Agaaz has manufacturing capabilities for advanced molecules including Cyclosporine, Sodium Hyaluronate, Olopatadine, Bepotastine Besilate, Nepafenac, Travoprost, and fixed-dose combinations such as Moxifloxacin-Ketorolac, Brimonidine-Timolol, Dorzolamide-Timolol, and Travoprost-Timolol.
ALPHRIN is a Brimonidine ophthalmic solution — a selective alpha-2 adrenergic agonist used for intraocular pressure reduction in open-angle glaucoma and ocular hypertension. It works by reducing aqueous humor production and increasing uveoscleral outflow.
Yes. Agaaz has established manufacturing capabilities for a wide range of advanced ophthalmic molecules and fixed-dose combinations. These new-generation formulations are available to qualified distribution partners on a committed volume basis. Contact the team with your molecule interest, country, and expected quantities to discuss availability and partnership terms.
Agaaz covers anti-glaucoma agents (Brimonidine, Travoprost, Timolol combinations), antibiotics (Moxifloxacin), anti-allergy drops (Olopatadine, Bepotastine), anti-inflammatory agents (Nepafenac, Ketorolac), dry eye therapy (Sodium Hyaluronate, Cyclosporine), and fixed-dose combination formulations — providing a comprehensive clinic and perioperative eye drops portfolio from a single source.
Agaaz Ophthalmics eye drops are manufactured in India under GMP-compliant facilities. Agaaz is based in Ahmedabad, Gujarat, and is a global exporter of ophthalmic surgical products — IOLs, OVDs, solutions, silicone oils, instruments, diagnostics, and eye drops — serving partners in 15+ countries.

Want to build your eye drops portfolio?

Share your target market, molecules of interest, and expected volume. We'll respond with availability, pricing, and a documentation checklist.